CPE-002 · Metabolic Pattern Intelligencev1.0.1-validation-betaValidation Beta · Synthetic Only

New Clinical Analysis

Enter structured laboratory values and documented clinical context, or load a synthetic validation case. The engine executes deterministically — identical inputs always yield identical outputs.

CPE-001 · Thyroid CPE-002 · Metabolic

Synthetic case

Patient Context

Age (years)

Sex for thresholds

Pregnancy status

Fasting hours

Anthropometry & Vital Signs

Weight (kg)

Height (cm)

Waist (cm)

Systolic BP

Diastolic BP

Waist circumference and blood pressure contribute to metabolic syndrome assessment when present. Missing components are surfaced as incomplete — never assumed normal.

Risk Modifiers & Physical Findings

Acanthosis nigricans (exam-confirmed)Multiple skin tags (contextual)First-degree family history of T2DPrior gestational diabetesPCOS documentedDocumented hepatic steatosis / MASLDRapid unintentional weight lossClassic hyperglycemia symptoms / crisis

Laboratory Data

Structured biomarker entry. The engine evaluates only documented values; absent fields remain absent in the reasoning trace.

Core Glycemic

Fasting Plasma Glucose (mg/dL)

Hemoglobin A1c (%)

OGTT 75 g · 2 h (mg/dL)

Random Plasma Glucose (mg/dL)

Potential HbA1c interference present

Lipid & Cardiometabolic

Triglycerides (mg/dL)

HDL-C (mg/dL)

Total Cholesterol (mg/dL)

ApoB (mg/dL) · optional

Supporting Physiology · Sandbox-Limited

Fasting insulin (uIU/mL)

Sandbox supporting calculation — threshold-based interpretation disabled until external clinical validation. HOMA-IR is computed when fasting is confirmed and there is no insulin / secretagogue interference.

Hepatic Review

ALT (U/L)

AST (U/L)

GGT (U/L) · optional

Platelets (10⁹/L) · optional

Persistent ALT elevation with cardiometabolic contextLiver risk review indicated

Safety & Differential

Ketones

Documented low glucose during symptomatic eventInappropriately elevated insulin during hypoglycemia